Harvard Bioscience Inc

HBIO

Company Profile

  • Business description

    Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

  • Contact

    84 October Hill Road
    HollistonMA01746
    USA

    T: +1 508 893-8999

    E: [email protected]

    https://www.harvardbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    355

Stocks News & Analysis

stocks

Unwarranted drop in ASX share

Jittery investors misinterpret an audit for an existential crisis.
stocks

Macquarie: A return to group-wide growth

Our view on the shares after earnings.
stocks

After earnings, is Disney stock a buy, a sell, or fairly valued? -

Following the highly anticipated announcement of a new CEO, here’s what we think of Disney.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,139.9034.50-0.38%
CAC 408,327.884.600.06%
DAX 4024,987.8527.02-0.11%
Dow JONES (US)50,433.97298.100.59%
FTSE 10010,353.8432.39-0.31%
HKSE27,183.15155.990.58%
NASDAQ23,250.5411.870.05%
Nikkei 22557,650.541,286.602.28%
NZX 50 Index13,513.6867.310.50%
S&P 5006,975.7010.880.16%
S&P/ASX 2008,867.4044.20-0.50%
SSE Composite Index4,128.375.280.13%

Market Movers